The Valley Desk

ArticleInternational journal of cancerPublished

Characterization of bridging therapies in clinical trials leading to FDA approval of CAR-T cell therapies

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Drexel University College of Medicine, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
International journal of cancer
Published
Subject terms
Humans; Neoplasms; Etoposide; Dexamethasone; Receptors, Antigen, T-Cell; Deoxycytidine; Immunotherapy, Adoptive; Cross-Sectional Studies; Drug Approval; United States Food and Drug Administration; United States; Clinical Trials as Topic
PubMed ID
40394455
Added to directory
Source checked

Report a correction or request removal